Search Within

Michael David Offin

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (26)
  2. Journal Article (23)
Groups
  1. Biostatistics Service (49)
  2. Department of Medicine (49)
  3. Epidemiology and Biostatistics (49)
  4. Solid Tumor Oncology Division (49)
  5. Thoracic Oncology (49)
  6. Weinberg Fellows (49)

More Groups

People
  1. Charles Rudin (34)
  2. Bob Li (31)
  3. Mark Kris (31)
  4. Maria Arcila (25)
  5. Alexander Drilon (23)
  6. Gregory Riely (19)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (3)
  4. 2022 (5)
  5. 2021 (7)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (14)
  2. Journal of Thoracic Oncology (10)
  3. Clinical Cancer Research (3)
  4. Annals of Oncology (2)
  5. International Journal of Radiation Oncology, Biology, Physics (2)
  6. JCO Precision Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (16)
  2. Elsevier Inc. (15)
  3. American Association for Cancer Research (4)
  4. Nature Publishing Group (4)
  5. Oxford University Press (3)
  6. Nature Research (2)

More Publishers

Results (49)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Correlation of histologic features with gene alterations in pleural mesothelioma
    Journal Article

    Fanaroff, R. E.; Yang, S. R.; Tan, K. S.; Adusumilli, P. S.; Bodd, F.; Bowman, A.; Chang, J.; Offin, M. D.; Reiner, A.; Rekhtman, N.; more...
    Modern Pathology (2025)

    Fulltext@MSK | Save
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • A model for approaching pathologic assessment of treatment response to neoadjuvant chemotherapy in resected pleural mesothelioma
    Meeting Abstract

    Aly, R. G.; Offin, M.; Tan, K. S.; Bodd, F.; Adusumilli, P.; Travis, W.; Zauderer, M.; Sauter, J.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase 2 study of amivantamab plus lazertinib in patients with EGFR-mutant lung cancer and active central nervous system disease
    Meeting Abstract

    Yu, H. A.; Chen, M. F.; Hui, A. B.; Choudhury, N. J.; Lee, J. J. K.; Zheng, J.; Ahn, L. S. H.; Pupo, A.; Nesselbush, M.; Jabara, I.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma
    Journal Article

    Shin, J. Y.; Offin, M.; Simone, C. B. 2nd; Zhang, Z.; Shepherd, A. F.; Wu, A. J.; Shaverdian, N.; Gelblum, D. Y.; Gomez, D. R.; Sauter, J. L.; more...
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Phase I dose escalation trial combining olaparib and thoracic radiation therapy in extensive-stage small cell lung cancer
    Meeting Abstract

    Rimner, A.; Lok, B.; Gelblum, D. Y.; Kotecha, R. R.; Albrecht, F.; Shin, J. Y.; Laplant, Q.; Namakydoust, A.; Shepherd, A.; Gomez, D.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Liu, D.; Makker, V.; Buonocore, D. J.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Johnson, A.; Offin, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase 1 safety study of avelumab plus stereotactic body radiation therapy in malignant pleural mesothelioma
    Journal Article

    Rimner, A.; Adusumilli, P. S.; Offin, M. D.; Solomon, S. B.; Ziv, E.; Hayes, S. A.; Ginsberg, M. S.; Sauter, J. L.; Gelblum, D. Y.; Shepherd, A. F.; more...
    JTO Clinical and Research Reports (2023)

    Fulltext@MSK | Save
  • Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers
    Meeting Abstract

    DeMatteo, R.; Goldman, D. A.; Lin, S. T.; Buonocore, D. J.; Gao, J.; Chang, J. C.; Rekhtman, N.; Offin, M.; Yu, H. A.; Isbell, J. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save